Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Mechanical pain thresholds may be used to predict the next headache attack in patients with migraine.
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 for the treatment of acute migraine in adults.
Researchers explored alterations in PREEMPT protocol and the explanations for them using an anonymous questionnaire to headache clinicians.
The investigators observed greater brain activations in the frontal regions associated with cognitive regulation of pain after CBT.
The aim of this study was to analyze trends in managing and treating migraine headaches in urgent care facilities, along with prescriptions and instructions given to this patient population upon discharge.
Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
The FDA has approved Elyxyb an oral solution formulation of celecoxib, for the acute treatment of migraine with or without aura in adults.
Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines.